CFR’s Global Monetary Policy Tracker compiles data from 54 countries around the world to highlight significant global trends in monetary policy. Who is tightening policy? Who is loosening policy ...

Eli Lilly expects to provide results from a study in people with obesity and osteoarthritis of the knee in 2025.

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers. The world's largest and longest ...

In this article, we are going to take a look at where Global Partners LP (NYSE:GLP) stands against other oil & gas stocks that are skyrocketing so far in 2025. The oil & gas sector has been quite ...

The success of these studies is a true testament to the effectiveness, versatility, and promise of our proprietary DehydraTECH technology platform within, and outside of, GLP-1…Our R&D plans for ...

The CFR Global Imbalances Tracker can be used to gauge, through time, the vulnerability of individual countries and the global economy to the buildup of imbalances in the current account (of which ...

Kerry, a global business in taste and nutrition, has outlined five distinct consumer segments among those who consume GLP-1s, each with unique preferences and needs, providing a framework for future ...

Does GLP-1RA use impact the risk of thyroid cancer? GLP-1RAs are highly effective medications used to treat T2D and obesity while simultaneously conferring protection against cardiovascular ...

Josh Gad is opening up about the weight loss success he’s had with GLP-1 medication — and sharing some of the conflicted feelings he’s had along the way. “I’m on a GLP-1 … this is the ...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this ...

Tech stocks plunged Monday morning, as fears mounted that Chinese artificial intelligence firm DeepSeek leapfrogged U.S. dominance in AI development.Jan. 27, 2025 ...

“Our study confirms the increased likelihood of being diagnosed with what appears to be low-risk thyroid cancer after treatment with GLP-1 RAs — but not because patients treated with GLP-1 RAs ...